Skip to content

RVMDW

Revolution Medicines, Inc.

NASDAQ · Healthcare · Biotechnology · US

$8.69
+3.45%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
1.70x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
0.63x
Price / sales
—
Price / cash flow
-1.35x

Enterprise value

Enterprise value
-$1.6B
EV / sales
—
EV / EBITDA
0.97x
EV / EBIT
1.01x
Market cap
$1.7B

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026